STERIS Stock Forecast for 2023 - 2025 - 2030
Updated on 03/18/2024
STERIS Stock Forecast and Price Target
The average price target for STERIS's stock lately set by several renowned analysts is $245.00, which would result in a potential upside of approximately 4.77% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of $265.00 and a low estimate of $215.00. If you want to buy STE stock, it might be a good idea to look at its competitors too.
4.77% Upside
STERIS Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's Price has grown by 45.39%, from $145.68 to $211.81. For the next year, analysts are expecting Fair Value to reach $251.07 – an increase of 18.54%. Over the next seven years, experts predict that Fair Value will grow by 20.11%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
AAPL Stock Forecast | Apple | Outperform |
16
|
$172.75 | Buy/Sell | $200.65 | 15.77% |
AMZN Stock Forecast | Amazon.com Inc | Buy |
13
|
$171.96 | Buy/Sell | $204.68 | 19.21% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$161.23 | Buy/Sell | $174.55 | 5.44% |
A005930 Stock Forecast | Samsung Electronics | Outperform |
10
|
₩72.40k | Buy/Sell | ₩92.49k | 31.22% |
ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$120.19 | Buy/Sell | $118.92 | 4.83% |
STERIS Revenue Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's Revenue has grown by 63.58%, from $3.03B to $4.96B. For the next year, analysts are expecting Revenue to reach $5.30B – an increase of 6.87%. Over the next seven years, experts predict that Revenue will grow by 65.45%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
DHR Stock Forecast | Danaher | Outperform |
10
|
$252.80 | Buy/Sell | $260.33 | 2.85% |
GE Stock Forecast | General Electric | Outperform |
8
|
$166.56 | Buy/Sell | $144.00 | 6.27% |
NKE Stock Forecast | NIKE Inc | Outperform |
16
|
$101.08 | Buy/Sell | $123.50 | 23.66% |
STERIS Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's Dividend per Share has grown from $1.45 to $1.84 – a 26.90% increase. Next year, analysts are expecting Dividend per Share to reach $1.90 – an increase of 3.26%. Over the next seven years, the forecast is for Dividend per Share to grow by 6.37%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$355.59 | Buy/Sell | $353.16 | 1.38% |
ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$378.90 | Buy/Sell | $408.45 | 11.38% |
MDT Stock Forecast | Medtronic | Outperform |
11
|
$85.50 | Buy/Sell | $92.47 | 11.11% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$66.12 | Buy/Sell | $70.14 | 8.89% |
BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$239.50 | Buy/Sell | $284.47 | 16.91% |
ECL Stock Forecast | Ecolab | Hold |
18
|
$223.90 | Buy/Sell | $205.36 | 1.38% |
STERIS EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's EBITDA has grown by 79.81%, rising from $743.18M to $1.34B. For next year, analysts predict EBITDA of $1.63B, which would mean an increase of 21.85%. Over the next seven years, experts predict that STERIS's EBITDA will grow at a rate of 28.16%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$90.83 | Buy/Sell | $91.18 | 1.84% |
MMM Stock Forecast | 3M | Hold |
10
|
$94.05 | Buy/Sell | $109.39 | 15.90% |
RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£51.70 | Buy/Sell | £66.68 | 14.12% |
STERIS EBIT Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's EBIT has grown, rising from $545.94M to $783.43M – a growth of 43.50%. In the next year, analysts believe that EBIT will reach $1.33B – an increase of 69.36%. For the next seven years, the forecast is for EBIT to grow by 68.43%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
IDXX Stock Forecast | IDEXX Laboratories | Hold |
14
|
$548.31 | Buy/Sell | $583.92 | 9.43% |
KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$126.78 | Buy/Sell | $128.04 | -0.62% |
FTV Stock Forecast | Fortive | Outperform |
18
|
$84.87 | Buy/Sell | $86.47 | 3.69% |
STERIS EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, STERIS's EPS has grown by 45.39%, from $5.64 to $8.20. For the next year, analysts are expecting EPS to reach $9.72 – an increase of 18.54%. Over the next seven years, experts predict that EPS will grow by 20.11%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$115.48 | Buy/Sell | $108.07 | -0.42% |
GRMN Stock Forecast | Garmin | Hold |
18
|
$145.99 | Buy/Sell | $128.46 | -5.88% |
MTD Stock Forecast | Mettler-Toledo International | Hold |
13
|
$1.30k | Buy/Sell | $1.12k | -7.55% |